Abstract
The COVID-19 pandemic prompted immense work on the investigation of the SARS-CoV-2 virus. Rapid, accurate, and consistent interpretation of generated data is thereby of fundamental concern. Ontologies–structured, controlled, vocabularies–are designed to support consistency of interpretation, and thereby to prevent the development of data silos. This paper describes how ontologies are serving this purpose in the COVID-19 research domain, by following principles of the Open Biological and Biomedical Ontology (OBO) Foundry and by reusing existing ontologies such as the Infectious Disease Ontology (IDO) Core, which provides terminological content common to investigations of all infectious diseases. We report here on the development of an IDO extension, the Virus Infectious Disease Ontology (VIDO), a reference ontology covering viral infectious diseases. We motivate term and definition choices, showcase reuse of terms from existing OBO ontologies, illustrate how ontological decisions were motivated by relevant life science research, and connect VIDO to the Coronavirus Infectious Disease Ontology (CIDO). We next use terms from these ontologies to annotate selections from life science research on SARS-CoV-2, highlighting how ontologies employing a common upper-level vocabulary may be seamlessly interwoven. Finally, we outline future work, including bacteria and fungus infectious disease reference ontologies currently under development, then cite uses of VIDO and CIDO in host-pathogen data analytics, electronic health record annotation, and ontology conflict-resolution projects.
Funder
U.S. National Library of Medicine
NIH
Publisher
Public Library of Science (PLoS)
Reference126 articles.
1. The Pivotal Role of TMPRSS2 in Coronavirus Disease 2019 and Prostate Cancer;V Mollica;Future Oncology,2020
2. TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention?;K Stopsack;Cancer Discovery,2020
3. Sex Differences in Mortality from COVID-19 Pandemic;G Sharma;JACC Case Reports,2020
4. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality;J Jin;Frontiers in Public Health,2020
5. COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning;E Ong;Front. Immunol,2020